Merck develops alternative CRISPR genome editing method

Phil Baran about his research and what makes a good chemist

Grzybowski Scientific Inventions (GSI)’s Chematica can design chemically viable synthetic pathways for complex targets within seconds

85 % think that a curios person is more likely to bring an idea to life at work according to a study from Merck

Merck invests around € 30 million in Darmstadt, Germany

Stefan Oschmann appointed Executive Board Chairman and CEO of Merck KGaA

Medicinal chemists develop a new lead candidate against overactive bladder

Merck and the University of Cape Town to Develop a Drug Discovery Platform for Malaria

Merck announced the completion of its $ 17 billion acquisition of Sigma-Aldrich

Effective September 30, Merck’s largest business sector will be governed by the Healthcare Executive Committee